div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: Serum concentrations of asymmetric ADMA and symmetric SDMA dimethylarginine in renal failure patients src=https:reader036vdocumentsmxreader036viewer20220825085750244b1a28ab877eae2be0html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: Serum concentrations of asymmetric ADMA and symmetric SDMA dimethylarginine in renal failure patients src=https:reader036vdocumentsmxreader036viewer20220825085750244b1a28ab877eae2be0html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: Serum concentrations of asymmetric ADMA and symmetric SDMA dimethylarginine in renal failure patients src=https:reader036vdocumentsmxreader036viewer20220825085750244b1a28ab877eae2be0html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: Serum concentrations of asymmetric ADMA and symmetric SDMA dimethylarginine in renal failure patients src=https:reader036vdocumentsmxreader036viewer20220825085750244b1a28ab877eae2be0html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 5button div class=ts-image amp-img class=ts-thumb alt=Page 5: Serum concentrations of asymmetric ADMA and symmetric SDMA dimethylarginine in renal failure patients src=https:reader036vdocumentsmxreader036viewer20220825085750244b1a28ab877eae2be0html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdiv